A recent study in this laboratory of recurrent attacks of experimental pneumococcus lobar pneumonia in dogs (1) revealed the fact that while one attack results in an increased antipneumococcal immunity, it is not of suflficient degree to protect the animal against subsequent infection with the same or even smaller infecting doses of pneumococci. Evidences of increased resistance of the recovered dogs were (a) regular survival from doses of culture which usually produced death in the dog infected for the first time, (b) the mild and brief course of the recurrent attack, (c) the limitation of the lesion in most instances to one lobe, (d) the low incidence of bacteremla. Investigation into the nature of the dog's greater ability to withstand recurrent infections indicated that it could not be related to the development of acquired circulating immune bodies alone since these substances were not found to be constantly present in the blood. Dogs without demonstrable humoral immunity appeared to be just as resistant to infection as those possessing it. However, a comparative study of the pathogenesis of the secondary and primary lesions brought out certain striking differences between the two. The secondary lesions tended to evolve much more rapidly and were characterized by the early appearance of a generalized macrophage reaction which was associated with marked diminution in the number of pneumococci in the tissues or their complete absence. This characteristic cellular transformation of the inflammatory exudate accompanied by the disappearance of the invading microorganisms has been found regularly at the time of recovery from the primary infection (2). Hence these findings in the reinfected dogs suggest 
A recent study in this laboratory of recurrent attacks of experimental pneumococcus lobar pneumonia in dogs (1) revealed the fact that while one attack results in an increased antipneumococcal immunity, it is not of suflficient degree to protect the animal against subsequent infection with the same or even smaller infecting doses of pneumococci. Evidences of increased resistance of the recovered dogs were (a) regular survival from doses of culture which usually produced death in the dog infected for the first time, (b) the mild and brief course of the recurrent attack, (c) the limitation of the lesion in most instances to one lobe, (d) the low incidence of bacteremla. Investigation into the nature of the dog's greater ability to withstand recurrent infections indicated that it could not be related to the development of acquired circulating immune bodies alone since these substances were not found to be constantly present in the blood. Dogs without demonstrable humoral immunity appeared to be just as resistant to infection as those possessing it. However, a comparative study of the pathogenesis of the secondary and primary lesions brought out certain striking differences between the two. The secondary lesions tended to evolve much more rapidly and were characterized by the early appearance of a generalized macrophage reaction which was associated with marked diminution in the number of pneumococci in the tissues or their complete absence. This characteristic cellular transformation of the inflammatory exudate accompanied by the disappearance of the invading microorganisms has been found regularly at the time of recovery from the primary infection (2) . Hence these findings in the reinfected dogs suggest 705 that their heightened resistance depends to a considerable extent on an accelerated reactivity of the pulmonary tissue ceils. But whether the effective antipneumococcal reaction of the macrophages requires the cooperation of acquired humoral immune substances, which may be present locally or in the blood in concentration below our methods of detection, we do not know.
Our reported observations on recurrent attacks of experimental pneumonia would indicate that the degree of the dog's increased immunity was not affected greatly by the number of infections to which it had been subjected. An animal having passed through eight or ten attacks appeared to be no more resistant to subsequent infection than following the first one. 1 Nor could we detect any significant differences in the local cellular response or the degree of humoral immunity that could be related to the number of infections. The question then arose as to whether or not the dog's antipneumococcal resistance could be increased to the point of complete protection against experimental infection. With the purpose of investigating this possibility the following experiments were undertaken.
Materials and Methods
Normal dogs, weighing 8 to 16 kilos, were used. The pneumococcus employed for producing infection was the same we have used in previous studies. It was of relatively high virulence for dogs, even when injected intraperitoneally or intrapleurally. 1 to 2 cc. regularly produced death. Intrabronchially the lethal dose was much smaller. The technique of infection has been described in an earlier publication (3) . For the sake of uniformity, the infecting dose, 0.25 cc. of an actively growing culture, was always introduced into the right lower lobe. This dose produced in normal dogs a severe and extensive pneumonia terminating fatally in approximately 65 per cent of the animals infected. X-ray of the dog's chest was taken at the end of 24 hours after infection except when the animal was sacrificed at this time. The concentrated antibody solution (Felton) employed was kindly given to us by Lederle and Company. The dogs were killed by means of rapid intravenous infection of 500 to 600 rag. of nembutal which produced instantaneous death. The tissues were fixed in 5 per cent acetic Zenker's solution and stained with Wallace's modification of the GramWeigert stain (4).
1 Observations extended since this work was completed have shown that dogs recovered from a number of pulmonary infections do have a greater antipneumococcal immunity than that acquired from a single attack of the experimental disease. However, this heightened immunity is of limited duration.
Effects of Passive Immunization
Although the sera of dogs having recovered from one or more attacks of the experimental disease frequently possess the property of passively immunizing mice against pneumococcus infection, the degree of such protective action is by no means as great as that which can be induced in the dog's blood by the injection of a large quantity of therapeutic immune serum. Therefore, it was felt that our failure to detect any constant relationship between the presence of humoral immunity and the recovered dog's resistance to the inception of experimental pneumonia did not exclude the possibility of producing effective protection by means of a high concentration of circulating immune substances. Accordingly, dogs were injected 15 to 20 minutes prior to infection with concentrated as well as raw Type I antipneumococcus serum, in quantities equivalent to those customarily administered to pneumonia patients in the first 24 hours of the disease. The serum of dogs thus treated usually protected mice against 0.01 cc. of pneumococcus culture, whereas the serum of recovered dogs showing mouse protective properties was effective against 0.0001 cc. of culture at most.
The three animals thus prepared, Nos. liB, 12B and 48G (Table  I) , all developed a lobar consolidation accompanied by fever. The disease ran a brief course 36 to 42 hours and the lesion was confined to a single lobe. One dog, 48G, sacrificed at the end of 42 hours, showed sterile cultures of the consolidated lung. Resolution of the lesions in the other two animals as determined by x-ray was very rapid. Several other dogs similarly treated (not listed in the table) confirmed the result of this experiment, namely, that even a high concentration of circulating antipneumococcal immune substances, when produced in this manner, does not protect the dog against the inception of the experimental disease.
Effects of Passive Immunization Combined with Leucocytosis
In an earlier study of the pathogenesis of experimental canine lobar pneumonia (5) it was observed that the spreading margin of the lesion was characterized by a peripheral zone of edema-filled air sacs containing large numbers of pneumococci. This was followed by a progressive accumulation of polymorphonuclear leucocytes in the 
~lveoli with attendant phagocytosis of the microorganisms. In the more central, i. e., older areas of the lesion, the alveoli were packed with leucocytes and the pneumococci had diminished greatly in numbers. It was apparent that a certain time interval elapsed before the arrival of the leucocytes in numbers sufficient to check the growth of the invading microorganisms. Meanwhile, the rapidly multiplying pneumococci brought about a progressive diminution in the concentration of opsonins present. This interval presumably allowed further spread of the infected edema fluid. Were this the correct account of the process, it would seem that given a sufficiently increased rate of mobilization of the phagocyting cells and the presence of an adequate concentration of opsonizing fluid, rapid termination of the infectious process would ensue. An attempt was made to produce such optimum conditions by the induction of a preliminary leucocytosis. For this purpose typhoid vaccine was employed. 1 cc., of the commercial preparation containing 1 billion bacilli, was injected subcutaneously the day preceding infection. At the height of the rise in circulating white blood cells, predominantly polymorphonuclear leucocytes, 20,000 units of antibody solution in one instance and 30 cc. of raw immune serum in the other, were injected intravenously, followed in 15 minutes by the infecting dose. Just as in the case of the dogs with passive immunization alone, these two animals (dogs 43G and 26G, Table I ) developed lobar consolidation. One of them, 26G, showed no rise in temperature but at postmortem two-thirds of the right lower lobe was found to be consolidated and small areas of involvement were present in the right middle and upper lobes. Cultures of the lungs and heart's blood were sterile in both animals, indicating that the active phase of the disease had terminated within 24 hours.
Effects of Injection of Polymorphonuclear Leucocytes Locally
It would appear that the induction of an antecedent leucocytosis added nothing detectable to the passively immunized dog's resistance. Was this due to the fact that the mobilization of leucocytes at the site of infection was not sufficiently accelerated? With the purpose of determining the effect of an initial high concentration of phagocyting cells at the locus of implantation, young active polymor-phonuclear leucocytes in the calculated proportion of twenty-five cells to one pneumococcus were mixed with the starch suspension containing the infecting dose of pneumococci. 2 This procedure apparently conferred no increased protection against infection as shown by the finding in dog 30L of extensive consolidation in the lungs at the end of 24 hours, a picture similar to that produced by analogous doses of culture in normal animals.
Effects of Injection of Polymorphonuclear Leucocytes Locally and Antibody Solution Intravenously
The next step was to produce a high concentration of immune substances in the blood and an effective mobilization of the leucocytes locally. The experiment on dog 29L was designed to produce such conditions, but either they were not adequately induced or there were other unknown necessary factors lacking, for autopsy of this animal at 24 hours revealed consolidation not only of the initially infected lobe but also metastatic lesions to the opposite side. Furthermore, pneumococci were recovered in culture from all the lesions. This extensive infection occurred despite a high degree of humoral immunity as shown by the fact that the dog's serum, taken immediately before inoculation, protected mice against 0.01 cc. of pneumococcus culture, 1 million or more lethal mouse doses.
Effects of Injection of Polymorpkonuclear Leucocytes and Antibody Solution Locally
In order to produce the most unfavorable environment for the freshly implanted pneumococci that we could devise, antibody solution and leucocytes were mixed directly with the starch containing the infecting dose of culture. The concentration of leucocytes was These leucocytes were obtained from an aleuronat pleural exudate produced in another normal dog and prepared as described in an early publication. In carrying out pnenmococcidal tests with normal dog serum and leucocytes it was found that a ratio of 50 polymorphonuclear leucocytes to 1 pneumococcus was the optimum for the complete destruction of all the pneumococci present. When immune serum was added to such mixtures, a ratio of 5 leucocytes to 1 pneumococcus was adequate (6, 7) . In the present work a mixture containing more than 25 leucocytes to 1 microorganism was found to be too viscid for intrabronchial injection.
the same as that in the preceding experiments. The amount of antibody solution used, 500 units, was calculated from our in vitro experiments as being in excess of that capable of causing, in conjunction with the leucocytes, the destruction of all the pneumococci injected (7). Dogs 77L and 17M (Table I) represent experiments of this type. It is possible that dog 77L was almost completely protected since there was no febrile reaction, its white count before death was only slightly elevated and the size of the lesion, 3 cm. in diameter, was not much larger than that produced by starch alone. Microscopically, however, the appearance of the lesion was more that of a pneumococcus infection than a starch inflammation. Cultures were sterile. Dog 17M, on the other hand, had a consolidation of half the lobe.
A third dog, 75L, was given immune serum locally but no leucocytes. There was a resulting rise in temperature in contrast to the two animals receiving immune serum and leucocytes, and consolidation of about the same extent and character as shown by dog 17M. How much importance should be attached to fever under these circumstances is not clear since certain animals (26G and 6L), developing more extensive lesions than shown by any of these three, exhibited no febrile reaction. The lesions in all three animals were sterile, indicating that recovery had occurred within 24 hours.
The above experiments leave one in doubt as to whether the injected leucocytes added anything to the dog's protective mechanism. The possibility that the phagocytic activity of the leucocytes might be impeded by the viscosity of the starch suspension was studied in vitro. And it was found that leucocytes mixed with starch were definitely less phagocytic than when suspended in serum alone. While the conditions in the capillary pipette and the lung differ in that there is constant movement in the latter and a gradual autolysis of the starch, it seemed not improbable that the artificially induced mobilization of the leucocytes might not be as effective at least during the first few hours of the disease, as that occurring naturally. Experiments were therefore devised to eliminate the interfering action of the starch.
It was first necessary to produce fatal experimental pneumonia without the use of starch. This was accomplished by injecting 0.25 cc. of culture suspended in 1 cc. of broth followed by 2 to 3 cc. of a very viscid mucin, s Of six dogs thus injected all developed severe pneumonia and five died.
Two dogs, Nos. 72Q and 73Q (Table I) , were injected with mixtures of leucocytes suspended in gelatin-Locke's solution, antibody solution and pneumococci without starch and followed by 2 to 3 cc. of mucin. 72Q was completely protected. On the other hand, a definite, though small pneumonic lesion involving one-fourth of the lobe developed in 73Q.
In order to compare the effectiveness of a small quantity of antibody solution (500 units) injected locally with a large quantity given intravenously, dog 43Q (Table I ) was infected in the same way as 72Q and 73Q except that 20,000 units of antibody solution were injected into the blood stream 1 hour and 15 minutes before giving the infecting dose of pneumococci mixed with leucocytes. From the fact that all three lobes of the right lung of dog 42Q were found to be consolidated at 24 hours, it would seem that the leucocytes might have been more of a hindrance than a help in the control of the infection. At any rate, a high concentration of antibodies in the blood of this dog was much less effective than small amounts of antibody solution deposited in the site of infection as shown by the small lesions in the seven dogs treated in this manner.
With the possibility that the lack of complete protection in dog 73Q injected with antibody solution and leucocytes locally might have been due to the absence of sufficient fresh serum to activate the immune bodies in the mixtures, 4 two more dogs, 61Q and 3R, were injected similarly, but with the difference that the leucocytes were suspended in fresh dog serum 0.5 to 0.75 cc. In neither dog were the lesions as small as in 72Q. Dog 3R showed consolidation of half the lobe. So it seems evident that the lack of added fresh serum was not responsible for the failure to secure complete protection in the earlier experiments.
To determine whether the limited lesions in the above experiments 8 The use of mucin in the production of experimental pneumonia was first introduced successfully by Nungester (8) . His method for the sterilization of mucin was employed in this work. The dog's chest was elevated during the procedure to prevent possible escape of the fluid.
4 In a previous study of the pneumococcidal action of mixtures of rabbit serum and leucocytes containing specific antipneumococcus serum it was found that the presence of a small amount of fresh normal serum was essential to the reaction (9).
were due to actual infection, a dog, 2R, was injected with leucocytes, antibody solution and killed pnenmococci. This animal, in contrast to the others similarly injected with live microorganisms, showed a rise in temperature although no increase in the number of white blood cells, and at autopsy had a lesion a little larger than that which would have been produced by the inoculum alone. In all the dogs injected with leucocytes locally the inoculum was 2 to 2.5 cc. so that an initial area of infiltration twice that of the 1 cc. of starch was produced. The nodule found in dog 72Q represents such an area.
The results of these experiments in which immune serum and leucocytes were artificially mobilized at the site of infection, show that while complete protection was uncommonly obtained, a febrile reaction was unusual, the lesions were small and all were sterile by 24 hours.
Effects of Passive Immunization Induced 24 Hours before Infection
Although none of the procedures employed in the preceding experiments were found to be regularly effective in preventing completely the inception of the experimental disease, there remained the possibility that the administration of immune serum some time before infection might produce a greater degree of protection. Accordingly, two dogs, Nos. 21V[ and 13iVf, were given 20,000 units of antibody solution 24 hours before the infecting dose of pneumococci. Dog 23¢f appeared to be completely protected (Table I) . Dog 13M, on the contrary, developed an infection characterized by the consolidation of a whole lobe, despite the fact that its blood serum, at the end of 24 hours, showed a high titer of mouse protective action. The lesion was found to be sterile.
Effects of Active Immunization with Vaccines and Live Cultures Injected Subcutaneously
The inquiry then proceeded to ascertain whether or not the production of active immunity, by means of killed and living pneumococcl, would protect more successfully against the induction of the experimental disease than did passive immunization. For this purpose dogs were immunized in various ways. Three animals, dogs 23H, 38H and 6M, were injected subcutaneously with killed cultures over
cJ a period of 2½ weeks, each animal receiving a total of 27 cc. of culture. 5 days after the last injection the dogs were given an infecting dose of culture intrabronchially. As will be noted in Table II , lobar consolidation occurred in all three instances and spreads to other lobes were found in the lungs of the two dogs sacrificed at 24 hours. The disease process, however, was short lived as shown by negative cultures from the initially consolidated lobes and the prompt recovery of dog 6• (not sacrificed). Before infection the sera of these dogs showed a considerable degree of humoral immunity, protecting mice against 0.001 to 0.0001 cc. of culture.
In an attempt to induce a higher degree of immunity, two other dogs, 6L and 15L, were given a much larger amount of vaccine as well as living pneumococci. The results were not essentially different from those in the dogs vaccinated less intensively. In fact there was some evidence that these animals, 6L and 15L, were not as resistant, in that the initially infected lobes still yielded positive cultures at the end of 24 hours while those of the dogs receiving the smaller vaccine doses were sterile at this time. Furthermore, while the initial titer of mouse protective substances in dogs 23H and 38H persisted until the time of death, the serum of dog 6L showed a marked diminution of this property during the 24 hours of the disease.
Effects of Intrabronchial Vaccination
A number of dogs were vaccinated intrabronchially by means of spraying suspensions of killed pneumococci directly into the lower bronchial tree through a long atomizer specially devised by Tuttle and Cannon (10) . Since this series of experiments is not yet complete and will constitute the subject of a separate report, only a brief mention of the results will be made at this time. It was found that vaccination by way of the bronchi resulted in an enhancement of the animal's resistance to pneumococcus infection, but not to the degree of preventing the inception of the experimental disease. The results were in general the same as those recorded in the case of dog 56L (Table II) . In every instance either a considerable part or a whole lobe became involved, but the disease was brief and invariably resulted in recovery. That the vaccine was absorbed from the lung surface was indicated by development of acquired immune substances in the blood sera of the vaccinated dogs. 
Effects of Combined Active and Passive Immunization
The question then arose as to whether the failure of either active or passive immunization alone to completely protect dogs against the experimental infection might not be due to the lack of some factor or factors which would be supplied by the combined action of both processes. This possibility was tested by means of passively immunizing dogs which had been vaccinated subcutaneously with killed pneumococci or had recently recovered from an attack of experimental pneumonia. As shown in Table III , one dog, No. 78L, recently recovered from experimental pneumonia and injected with 20,000 units of antibody solution 24 hours preceding infection, developed a lesion involving two-fifths of the lobe but without fever. The vaccinated dog, No. 30N, similarly treated, showed only a small area of consolidation which was, however, two to three times as large as that which would be produced by the starch alone. Both lesions were sterile at postmortem. Just where to place the line between complete and incomplete inhibition of infection, we do not know. In view of the fact that a sterile inoculum consisting of leucocytes and killed pneumococci (dog 2R, Table I ) caused an area of consolidation as large as that found in 30N, it may be that the latter animal should be considered to have been completely protected.
Comparison of the Protective Effect of Active versus Passive Immunization
A general comparison of the characteristics of the experimental infections produced in dogs actively immunized by recovery from an attack of the disease or vaccinated in the various ways described above, with those observed in animals passively immunized by intravenous injection of large quantities of highly potent immune serum, suggested that the latter procedure induced a somewhat greater degree of protection than did the former. It seemed worth while to pursue this subject further by means of testing the efficacy of the two types of immunity with highly lethal doses of pneumococci. In a recent series of experiments on the relationship of dosage to the outcome of experimental pneumonia it was found that implantation of the infecting dose, contained in 4 to 6 cc. of starch, into several different areas in the lung produced a much higher mortality than did similar amounts of culture contained in 1 cc. of starch) The dose chosen for the present test was 0.6 cc. culture, an amount which killed normal dogs within 24 to 48 hours.
Two animals were compared as follows: Dog 6M had had three previous attacks of lobar pneumonia, all in the right lower lobe, the last one 2 weeks before infection with the lethal dose which was initiated also in the right lower lobe. The normal dog, 26M, received 20,000 units of antibody solution 24 hours before infection. Tests on the blood serum taken just before the infecting dose showed t h a t the serum of 6M protected against 10 -4 dilution of culture while that of 26M protected against 10 -3. Both dogs survived. The brief course of the disease--2 to 3 days--, the extent of consolidation (lower and middle lobes) and the absence of bacteremia were the same in the two animals. The only difference between them was the occurrence of a marked leucopenia in the recovered dog at the end of 24 hours while in the passively protected animal the white blood cells fell only to a low normal count. With this exception the actively immunized dog appeared to be as resistant to the experimental infection as was the passively immunized one.
Since the above experiments were carried out several other dogs, having recovered from one or more attacks of experimental lobar pneumonia, were reinfected after 10 days to 2 weeks with the same lethal dose of pneumococci as was given to dogs 6M and 265I. These animals passed through a brief infection without showing an accompanying leucopenia.
Pathology
Most striking feature of histological pathology of these lesions was the presence of a macrophage reaction 6 24 hours after the inception of the disease. In normal animals the same degree and extent of this cellular change was not ob-5 Unpublished work. 6 The cellular transformation of the lung parenchyma and intra-alveolar exudate designated under the term "macrophage reaction" has been described by Robertson and coworkers in detail in former publications (1, 2) . Briefly it consists of an increase in the number and size of large mononudear cells in the alveolar walls, which become detached from the septa and enter the air spaces where they assume the appearance and functions of the free histiocyte or macrophage.
served to occur before 40 to 48 hours. The majority of the twenty-two animals studied showed a macrophage reaction in its beginning stages, i.e., thickened septa containing numerous large mononudear cells, many of which protruded into the alveolar spaces but relatively few free. In most instances the reaction was generalized, in a few focal in distribution. Three of the dogs exhibited the cellular change in a moderately advanced form. In three others it was very slight and focal in distribution, no more than is sometimes seen in primary infections at 24 hours. In all but one of the dogs (430.) showing metastatic lesions, the macrophage reaction was more marked in the newer process than it was in the original one. Likewise, with a single exception (dog 29L), the reaction was greater at the spreading margin of the lesion than at its center. This was, of course, not true of the three animals in which there was a well marked response of the macrophages throughout the inflavamatory area. The predominant cell type even in these three dogs was the polymorphonudear leucocyte.
Just as found in former studies (1, 2) pneumococci were few or absent in areas of macrophage accumulation. In only four of the dogs were pneumococci cultured from the lungs 24 hours after the inception of the infection. One of these, 30L, received only leucocytes with the infecting dose. Two, dogs 6L and 15L, were vaccinated with large quantities of killed and live cultures subcutaneously. The fourth animal, No. 29L, injected with antibody solution intravenously, developed only a small area of consolidation and was the single one of the four in which the lesions showed a macrophage reaction. This reaction in the initial lesion was slight in degree, focal in character and not present at the periphery where pneumococci were observed both free and intracellular. In the more central portion of the process only a few intraceUular microorganisms were seen. The metastatic lesions in dog 29L were characterized by a more pronounced and generalized macrophage response and, with the exception of a very occasional intracellular form, the absence of pneumococci. In most of the sterile lung lesions pneumococci could not be detected. In some, microorganisms were observed to be undergoing digestion, principally within the macrophages.
DISCUSSION
Previous studies on the prevention of experimental pneumococcus pneumonia have dealt almost entirely with the protective effects of vaccination by various routes. Cecil and Blake (11) found that saline and lipoid Type I pneumococcus vaccines injected subcutaneously failed to protect monkeys against intratracheal infection with virulent microorganisms of the same type, but the ensuing pneumonia was milder than in the non-vaccinated controls and bacteremia usually slight. Employing living cultures in the same manner they were able to induce a greater degree of protection which in two instances was apparently complete (12) . However, some of the monkeys showed marked reaction to the vaccination and even gave evidence of actual infection. Cecil and Steffen (13) pursued the investigation further, using very much larger doses of heat-killed pneumococci subcutaneously, a total of 120 billion microorganisms in three doses. They were able by this means to secure complete protection against the inception of experimental lobar pneumonia with Types I, II and group IV. Equally good results in the case of pneumococcus Type I were obtained by injecting the vaccine intratracheally. However, the same amount of vaccine sprayed into the trachea failed to protect. Cecil and Blake (14) reinfected two monkeys which had recovered from Type I lobar pneumonia and found them to be immune to infection with the homologous type pneumococcus. Whether the difference between the results of these workers and our own lies in the animal species employed or in the method of inducing the experimental disease, we do not know. Findings much more nearly comparable to ours in dogs were obtained by Stuppy, Cannon and Falk (15) , in rabbits protected by means of killed cultures of Type I pneumococci sprayed into the nose and throat and also injected into the buccal mucosa. Animals immunized by either route survived lethal doses of virulent pneumococci introduced by intrabronchial insuffiation. They showed pulmonary lesions which were, however, of limited extent and in the three rabbits killed at 24 or 48 hours after infection were found to be sterile. Microscopical examination of these lesions revealed a marked reaction of the pulmonary macrophages.
A comparison of the effects produced in the dog by the injection of pneumococci in various sites indicates that the implantation of starch-suspended microorganisms into the terminal air spaces of the lung provides a peculiarly favorable environment for their growth. Doses of broth culture, many times the amount required to produce pneumonia, when injected into the blood stream or under the skin of normal dogs were found to excite little or no reaction. Our successful production of pneumonia by the injection of pneumococci suspended in 1 co. of broth followed by 2 to 3 cc. of mucin which occludes the terminal bronchus completely, suggests that the most important function of the starch may be that of preventing the elimination of the microorganisms. In their original investigation, Nungester and Jourdonais (8) found that the invasiveness of pneumococci for rats was enhanced by suspension in mucin. While in the present work the mucin was injected after the infecting dose of pneumococci, a certain admixture of microorganisms and mucin probably occurred, especially since mucin so injected has been found not only at the site of insertion but also in neighboring bronchi 6 to 9 hours afterwards. Starch also protects the pneumococci from the phagocyting cells as we found in our opsonin tests i~ vitro. However, this latter effect is evidently o~ limited duration, since within an hour after the initiation of the primary lesion pneumococci were observed in alveolar spaces and to some extent in the alveolar walls at a considerable distance from the locus of implantation (5) . By the end of 4 to 6 hours all traces of the starch had disappeared. Therefore it would seem that once the disease has been initiated, the action of the starch, whatever it may be, ceases to operate. Certainly it can have nothing to do with the inception of the later metastatic lesions. The occasional occurrence of such lesions in highly immunized dogs is another evidence of the disadvantage at which the body is placed when pneumococci gain entrance to the alveolar units. For this reason it would seem to us that the method we have employed for testing the animals' power to resist the inception of lobar pneumonia is more exacting than those previously used, since in the latter many of the injected pneumococci probably never reached the alveolar spaces.
The results of the experiments described in this study provide some further insight into the mechanism by which the body brings about the termination of growth and the destruction of pneumococci in the lungs but leave much of the problem unsolved. The supposition (advanced earlier) (5) that a high concentration of antipneumococcal immune substances and phagocyfing cells at the site of infection would quickly bring about a termination of the process is borne out in the main by the present observations. However, the optimum conditions for securing such mobilization of the body's defenses remain obscure. The occurrence of lobar or multilobar consolidation in a number of the passively as well as in the actively immunized animals leaves no doubt that even a very high concentration of specific immune substances in the blood may not prevent the development of an extensive lesion. A preliminary artificial mobilization of polymorphonuclear leucocytes at the site of infection appeared to contribute no added protection. It was only when immune bodies and leucocytes were implanted with the infecting dose of pneumococci that a constant early inhibition of the infection occurred. 7 The fact that several of the passively immunized dogs were found to be completely or almost completely protected suggests that individual animals vary greatly in the rate at which the defensive dements of the blood can be mobilized at the site of infection. Even in those animals developing fairly extensive consolidation the rate of destruction of pneumococci was much greater than in the normal dog as shown by the sterile cultures of the lesions at 24 hours.
We have no direct evidence in this study that the immune serum has any action other than that of promoting phagocytosis and intracellular digestion. However, the markedly circumscribed nature of some of the initial loci of consolidation suggests that it may exert additional localizing effects described by Rich (19) and Catron (20) , namely agglutination and adhesion of the pneumococci to the tissue ceils, s
The early appearance of a macrophage reaction observed in the lesions brings up the question of the possible rSle played by these cells in termination of the infectious process. While it seems probable that the polymorphonuclear leucocytes were chiefly responsible for the destruction of pneumococci since they were the predominant cell of the inflammatory exudate, the finding that the macrophage response was most pronounced in the young metastatic lesions and at the margin of the initial loci of consolidation suggests a condition analogous to that which we have found to occur early in the lesions of recurrent infections produced at the site of a previous pneumonic 7 The recent studies of Goodner and HorsfaU and Bauer (16, 17) and Heidelberger and Pedersen (18) on the relative sizes of the horse and rabbit globulin molecules suggest the possibility that the smaller molecular size of the rabbit antipneumococcus immune bodies might permit their exudation into the inflammatory area in greater concentration than is possible with immune substances of horse serum. s Cannon and Pacheco had previously described this effect in staphylococcus infection (21) .
process. Such infections, usually brief and relatively mild, were characterized by pulmonary lesions exhibiting a much accelerated macrophage reaction. This was seen sometimes within 6 hours after the infecting dose of culture and just as in the case of the metastatic lesions described above, wherever the reaction was marked, pneumococci were few or absent. It is of considerable interest to note that there was no essential difference in cellular reaction between the animals actively and passively immunized. The exact beating of these experiments on the immunization of human beings against pneumonia is not clear since we have little information concerning the mode of origin of the human disease. Nevertheless our findings do suggest the kind of result that may be expected from any successful specific prophylactic procedure. It is beyond the scope of this communication to discuss the subject of the prevention of pneumonia by means of pneumococcus vaccines or certain derivatives of the pneumococcus. The success of the earlier work in this field has been questioned. 9 More recently, however, Lister and Ordman (22) and Peall (23) have reported a marked lowering of both morbidity and mortality from pneumonia among the laborers in certain South African mines by means of mixed vaccines comprising various types of pneumococci and other microorganisms commonly producing or complicating pneumonia. The inference which might be drawn from our results is that no matter how successful the procedure employed to increase the resistance of human beings to pneumococcus infection, there will be a certain percentage of such persons who will acquire the disease but the lesion will tend to be of limited extent and the infection of brief duration. We have observed one case of this kind due to pneumococcus Type II which terminated in the 18th hour. Serum secured shortly after onset showed a high concentration of heat stable Type II antipneumococcus immune substance.
SUMM_4~Y
In view of the finding that one or more attacks of pneumococcus lobar pneumonia experimentally induced in dogs failed to protect 9 This subject has been reviewed by Felton, Sutliff and Steele (24), Gautier (25) and Lister (22) . the animals against subsequent infection, an attempt was made to determine whether or not the dog's antipneumococcal immunity could be enhanced to the degree of complete resistance to the experimental disease. To this end dogs were passively immunized by the intravenous injection of large quantities of both unconcentrated antipneumococcus horse serum and concentrated antibody solution and actively immunized by vaccination with killed and living cultures of pneumococci. None of these procedures were found to result in constant protection against the pulmonary infection. The disease, however, was of brief duration, the lesions of limited extent and usually sterile within 24 hours. A combination of active and passive immunization produced no better results. It was only when immune bodies and leucocytes were implanted with the infecting dose that prevention of infection was secured with any degree of constancy. Even under these conditions the lesion sometimes involved a considerable portion of a lobe. The factors involved in the inception of experimental lobar pneumonia are discussed and the bearing of this study on the prophylactic immunization of human beings against pneumococcus pneumonia is suggested. 
